Roche Holding Limited
(OTCQX: RHHBY)
|
8:59 PM UTC, 02/21/25 | |||
---|---|---|---|---|
Last: $41.42 | Change: +0.27 | %Change: +0.66% | Volume: 1,901,207 |
Open: | $ 41.25 | Volume: | 1,901,207 | |
---|---|---|---|---|
High: | $ 41.57 | Yield(%) | 2.05 | |
Low: | $ 41.19 | P/E Ratio (ttm): | 27.92 | |
Dividend ($): | 0.85 | Market Cap ($): | 226.72B | |
EPS ($) | n/a | Shares Out: | 5.51B |
% Price Change (last 4 weeks): | 8.09 |
---|---|
% Price Change (last 13 weeks): | 16.61 |
% Price Change (last 26 weeks): | -0.68 |
% Price Change (last 52 weeks): | 26.65 |
% Price Change (year to date): | 17.98 |
Return on Equity (%): | 26.90 |
---|---|
Return on Assets (%): | 8.55 |
Return on Invested Capital (%): | 24.36 |
Gross Profit Margin (%): | 73.51 |
---|---|
Net Profit Margin (%): | 13.68 |
Operating Profit Margin (%): | 30.14 |
|
|
50-day Moving Average: | $37.38 |
---|---|
200-day Moving Average: | $37.20 |
Avg. Daily Vol. (last 50 days): | 1,505,869 |
Avg. Daily Vol. (last 200 days): | 1,687,765 |
52-wk high: | $42.43 |
52-wk low: | $29.20 |
Bid: | $n/a |
Ask: | $n/a |
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
|
Roche Holding Limited
Grenzacherstrasse 124 Basel BS 4058 Phone: 41.61.688.11.11 Fax: n/a http://www.roche.com |
Earnings (1year) ($): | 1.47 |
---|---|
Annual Dividend ($): | n/a |
Current P/E Ratio (ttm): | 27.92 |
Book Value ($): | 5.51 |
Cash Flow ($): | 2.41 |
Price/Earnings (x): | 27.92 |
---|---|
Price/Sales (x): | 3.26 |
Price/Book (x): | 6.33 |
Price/Cash Flow (x): | 10.28 |
Quick Ratio (x): | 1.20 |
---|---|
Current Ratio (x): | 1.48 |
LT Debt/Equity (x): | 101.04 |
Total Debt/Equity (x): | 114.44 |